edski

Author Archives

Recent Author Comments

On Microblog: Non Opioid drug going to be a game changer in Osteoarthritis?

$PAR:ASX ASX RELEASE 30th April 2021 QUARTERLY ACTIVITIES REPORT https://hotcopper.com.au/threads/ann-quarterly-update-and-appendix-4c-quarterly.6033470/[...]

Go to Comment »
On Microblog: Non Opioid drug going to be a game changer in Osteoarthritis?

PAR:ASX PARADIGM DOSES FIRST PARTICIPANT IN PARA_OA_008 CLINICAL TRIAL EXPLORING SYNOVIAL BIOMARKERS https://hotcopper.com.au/threads/ann-paradigm-doses-first-participant-in-synovial-fluid-trial.6005174/?source=email[...]

Go to Comment »
On Microblog: Non Opioid drug going to be a game changer in Osteoarthritis?

$PAR:ASX IND submitted to FDA https://hotcopper.com.au/threads/ann-paradigm-delivers-ind-to-us-fda-for-pivotal-oa-program.5978261/ https://hotcopper.com.au/threads/we-just-submitted-an-ind-so-now-what.5979687/[...]

Go to Comment »
On Microblog: Non Opioid drug going to be a game changer in Osteoarthritis?

$PAR:ASX Paradigm Announces 1HY21 Financial Results https://hotcopper.com.au/threads/ann-half-yearly-report-and-accounts.5925308/?source=email[...]

Go to Comment »
On Microblog: Non Opioid drug going to be a game changer in Osteoarthritis?

$PAR:ASX Cap51's B & C Series Investor Note at end of Jan - I'm sure they won't mind me posting it. https://www.fiftyonecapital.com/ January 2021 THE PROGRESSIVE GLOBAL FUND – B & C Class Unitholders Paradigm has consolidated nicely over 2020 and now l[...]

Go to Comment »
On Microblog: Non Opioid drug going to be a game changer in Osteoarthritis?

$PAR:ASX Trial registered on ANZCTR http://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=381039&isReview=true https://hotcopper.com.au/threads/trial-par008-is-on-anzctr.5902652/[...]

Go to Comment »
On Microblog: Non Opioid drug going to be a game changer in Osteoarthritis?

$PAR:ASX Paradigm appoints Helen Fisher as Non-Executive Director and Chair of the Audit and Risk Committee, effective 23rd of February. https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02340163-3A561028?access_token=83ff963[...]

Go to Comment »
On Microblog: Non Opioid drug going to be a game changer in Osteoarthritis?

$PAR:ASX https://hotcopper.com.au/threads/ann-39th-annual-jp-morgan-healthcare-conference-presentation.5853275/[...]

Go to Comment »
On Microblog: Non Opioid drug going to be a game changer in Osteoarthritis?

I've mentioned before PAR's Honorary Doctor of Research for PAR on the Hot Copper website. Below is a listing of all of his posts for 2020. Good reading and information for all. But please remember, to do your own research. While I feel that this resea[...]

Go to Comment »
On Microblog: Non Opioid drug going to be a game changer in Osteoarthritis?

On December 3, 2020, Paradigm was included in the 3rd Annual Evercore ISI HealthCONx Conference. https://wsw.com/webcast/evercore11/par.ax/2640450 In it, Mr.Paul Rennie, CEO of Paradigm, offered up a new timeline for Phase 3 trials. The market and shareh[...]

Go to Comment »
On Microblog: Non Opioid drug going to be a game changer in Osteoarthritis?

11/18/2020 Paradigm Biopharmaceuticals LTD (ASX:PAR) 2020 Annual General Meeting (AGM) Presentation https://hotcopper.com.au/threads/ann-paradigm-agm-presentation.5765642/?source=email[...]

Go to Comment »
On Microblog: Non Opioid drug going to be a game changer in Osteoarthritis?

$PAR:ASX FIRST PATIENT DOSED IN PHASE 2 CLINICAL TRIAL EVALUATING PPS IN MUCOPULYSACCHARIDOSES TYPE-1 (MPS-I) https://hotcopper.com.au/threads/ann-first-patient-dosed-in-mps-i-phase-2-clinical-trial.5750645/?source=email[...]

Go to Comment »
On Microblog: Non Opioid drug going to be a game changer in Osteoarthritis?

$PAR:ASX November 5, 2020 Australia NWR Virtual Investor Conference Hear from leaders of exciting growth companies on the ASX and ask questions live in an interactive setting https://www.youtube.com/watch?v=_GF89ABIk2I&feature=emb_logo&ab_channel=Par[...]

Go to Comment »
On Microblog: Non Opioid drug going to be a game changer in Osteoarthritis?

$PAR:ASX QUARTERLY ACTIVITIES REPORT https://www.google.com/search?q=quarterly+activities+report+asx&oq=QUARTERLY+ACTIVITIES+REPORT&aqs=chrome.1.0i457j0j0i22i30l4j69i60j69i61.4830j0j4&sourceid=chrome&ie=UTF-8[...]

Go to Comment »
On Microblog: Non Opioid drug going to be a game changer in Osteoarthritis?

$PAR:ASX An informative piece written by a holder of Paradigm, who writes about many possible involvements of iPPS in pain relief. https://hotcopper.com.au/threads/obese-people-do-not-walk-on-their-hands.5715340/?get_post=true[...]

Go to Comment »
On Microblog: Non Opioid drug going to be a game changer in Osteoarthritis?

$PAR:ASX PARADIGM ADDS MORE TALENTED SENIOR EXECUTIVES TO ITS TEAM https://hotcopper.com.au/threads/ann-paradigm-adds-more-talented-senior-executives-to-its-team.5682119/ Coppo Report https://hotcopper.com.au/attachments/47b6c546-900e-4db5-81ca-7039[...]

Go to Comment »
On Microblog: Non Opioid drug going to be a game changer in Osteoarthritis?

$PAR:ASX Paradigm locks into 25 exclusive agreement with bene pharmaceuticals https://hotcopper.com.au/threads/ann-extension-of-exclusive-agreement-with-bene-pharmachem.5651795/[...]

Go to Comment »
On Microblog: Non Opioid drug going to be a game changer in Osteoarthritis?

Latest release from Paradigm regarding more great news about Positive feedback received from European Medicines Agency (EMA) after Paradigm’s recent Scientific Advice meeting. https://hotcopper.com.au/threads/ann-ema-provides-key-path-toward-phase-3-tri[...]

Go to Comment »
On Microblog: Non Opioid drug going to be a game changer in Osteoarthritis?

Most publications or stock groups have one or two extra special shareholders that go above and beyond and forward their research to the other members. On Hot Copper, (HC): https://hotcopper.com.au/asx/par/?keywords=PAR, we have one such researcher know[...]

Go to Comment »
On Microblog: Non Opioid drug going to be a game changer in Osteoarthritis?

$PAR:ASX Posted 8/27/20 Over the last few years, Paradigm Biopharmaceuticals (PAR) has grown from an unknown small cap to a $600 million dollar drug developer. With trials and approvals moving along at a steady pace, Scott Williams from Fiftyone Capital[...]

Go to Comment »

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info